A detailed history of Hedges Asset Management LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Hedges Asset Management LLC holds 3,450 shares of AXNX stock, worth $232,426. This represents 0.17% of its overall portfolio holdings.

Number of Shares
3,450
Previous 8,600 59.88%
Holding current value
$232,426
Previous $535,000 55.7%
% of portfolio
0.17%
Previous 0.42%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$56.67 - $69.36 $291,850 - $357,204
-5,150 Reduced 59.88%
3,450 $237,000
Q4 2023

Jan 10, 2024

BUY
$49.38 - $63.75 $25,924 - $33,468
525 Added 6.5%
8,600 $535,000
Q3 2023

Oct 31, 2023

BUY
$48.64 - $62.51 $392,768 - $504,768
8,075 New
8,075 $453,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.31B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Hedges Asset Management LLC Portfolio

Follow Hedges Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hedges Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hedges Asset Management LLC with notifications on news.